Search - tctmd.com

Displaying 1 - 20 of 118

Sort: Relevancy | Date

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Michael O'Riordan

November 09, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Daily News

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Todd Neale

October 22, 2018

Presentation

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

October 03, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

PORTICO I: One-Year Outcomes With a Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

Presenter: James B. Hermiller Jr, Lars Sondergaard

September 25, 2018

Presentation TCT 2018

NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

Presenter: James B. Hermiller Jr, Azeem Latib

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

Case #7: Mitral Valvuloplasty and TAVR in a Patient With Mitral and Aortic Stenosis

Presenter: Vinay K. Bahl, David R. Holmes Jr., Roberto J Cubeddu, Eduardo De Marchena, Mayra Guerrero, Alexander Llanos, Rahul Sakhuja, Christian F. Witzke

September 24, 2018

Presentation TCT 2018

The Other Type Of Aortic Stenosis: Complex Aortoiliac Occlusive Disease

Presenter: Sahil A. Parikh, Christopher J. White, Vikas Aggarwal, J. Michael Bacharach, Brian G. DeRubertis, Virendra I Patel, Mahmood K. Razavi, Rahul Sakhuja, Ramon L Varcoe, Craig M. Walker

September 24, 2018

Presentation TCT 2018

CENTER-Collaboration II: Incidence, Predictors, and Outcomes of Stroke in Patients Undergoing Transcatheter Heart Valve Implantation for Severe Aortic Stenosis

Presenter: Charles J. Davidson, Francesco Maisano, Wieneke Vlastra

September 24, 2018

Presentation TCT 2018

DIRECT: A Randomized Trial Evaluating Predilatation Prior to Implantation of a Self-Expanding Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

Presenter: Charles J. Davidson, Francesco Maisano, Konstantinos Toutouzas

September 24, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

Advertisement

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Complications Following TAVR Are Going Down, US Data Show

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

PORTICO I: One-Year Outcomes With a Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Case #7: Mitral Valvuloplasty and TAVR in a Patient With Mitral and Aortic Stenosis

The Other Type Of Aortic Stenosis: Complex Aortoiliac Occlusive Disease

CENTER-Collaboration II: Incidence, Predictors, and Outcomes of Stroke in Patients Undergoing Transcatheter Heart Valve Implantation for Severe Aortic Stenosis

DIRECT: A Randomized Trial Evaluating Predilatation Prior to Implantation of a Self-Expanding Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content